Cameron J Turtle

Cameron J Turtle

UNVERIFIED PROFILE

Are you Cameron J Turtle?   Register this Author

Register author
Cameron J Turtle

Cameron J Turtle

Publications by authors named "Cameron J Turtle"

Are you Cameron J Turtle?   Register this Author

53Publications

1309Reads

21Profile Views

Patient-Reported Neuropsychiatric Outcomes of Long-Term Survivors after Chimeric Antigen Receptor-T Cell Therapy.

Biol Blood Marrow Transplant 2019 Oct 9. Epub 2019 Oct 9.

Division of Clinical Research; Department of Medicine, University of Washington, Seattle, WA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2019.09.037DOI Listing
October 2019

Late Events after Treatment with CD19-Targeted Chimeric Antigen Receptor Modified T Cells.

Biol Blood Marrow Transplant 2019 Aug 13. Epub 2019 Aug 13.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Medicine, University of Washington, Seattle, Washington. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2019.08.003DOI Listing
August 2019

Insight into mechanisms associated with cytokine release syndrome and neurotoxicity after CD19 CAR-T cell immunotherapy.

Bone Marrow Transplant 2019 Aug;54(Suppl 2):780-784

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41409-019-0602-5DOI Listing
August 2019

Reply.

Biol Blood Marrow Transplant 2019 Jun 23;25(6):e211-e212. Epub 2019 Mar 23.

The University of Texas M.D. Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2019.03.019DOI Listing
June 2019

Toxicities of CD19 CAR-T cell immunotherapy.

Am J Hematol 2019 May 6;94(S1):S42-S49. Epub 2019 Mar 6.

Clinical Research Division and Integrated Immunotherapy Research Center, Fred Hutchinson Cancer Research Center, Seattle, Washington.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25445DOI Listing
May 2019

Not so crystal clear: observations from a case of crystalline arthritis with cytokine release syndrome (CRS) after chimeric antigen receptor (CAR)-T cell therapy.

Bone Marrow Transplant 2019 Apr 5;54(4):632-634. Epub 2018 Oct 5.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s41409-018-0357-4
Publisher Site
http://dx.doi.org/10.1038/s41409-018-0357-4DOI Listing
April 2019

Neurotoxicity Associated with CD19-Targeted CAR-T Cell Therapies.

CNS Drugs 2018 12;32(12):1091-1101

Clinical Research Division and Integrated Immunotherapy Research Center, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40263-018-0582-9DOI Listing
December 2018

Insights into cytokine release syndrome and neurotoxicity after CD19-specific CAR-T cell therapy.

Curr Res Transl Med 2018 05 3;66(2):50-52. Epub 2018 Apr 3.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States; Department of Medicine, University of Washington, Seattle, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.retram.2018.03.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5967886PMC
May 2018

Driving CARs Across New Borders.

Hum Gene Ther 2018 05;29(5):529

1 Clinical Research Division, Fred Hutchinson Cancer Research Center , Seattle, Washington.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/hum.2018.29065.cjtDOI Listing
May 2018

Graft-Derived Reconstitution of Mucosal-Associated Invariant T Cells after Allogeneic Hematopoietic Cell Transplantation.

Biol Blood Marrow Transplant 2018 02 9;24(2):242-251. Epub 2017 Oct 9.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Medicine, University of Washington, Seattle, Washington.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2017.10.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5806215PMC
February 2018

CD19-specific chimeric antigen receptor-modified (CAR)-T cell therapy for the treatment of chronic lymphocytic leukemia in the ibrutinib era.

Immunotherapy 2018 02;10(4):251-254

Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/imt-2017-0162DOI Listing
February 2018

Absence of Replication-Competent Lentivirus in the Clinic: Analysis of Infused T Cell Products.

Mol Ther 2018 01 12;26(1):280-288. Epub 2017 Sep 12.

Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104-5156, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ymthe.2017.09.008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762981PMC
January 2018

Durable Molecular Remissions in Chronic Lymphocytic Leukemia Treated With CD19-Specific Chimeric Antigen Receptor-Modified T Cells After Failure of Ibrutinib.

J Clin Oncol 2017 Sep 17;35(26):3010-3020. Epub 2017 Jul 17.

Cameron J. Turtle, Kevin A. Hay, Laïla-Aïcha Hanafi, Shelly Heimfeld, Stanley R. Riddell, and David G. Maloney, Fred Hutchinson Cancer Research Center; Cameron J. Turtle, Sindhu Cherian, Xueyan Chen, Brent Wood, Stanley R. Riddell, and David G. Maloney, University of Washington; Daniel Li, Juno Therapeutics, Seattle, WA; and Arletta Lozanski and John C. Byrd, The Ohio State University, Columbus, OH.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.72.8519DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5590803PMC
September 2017

Chimeric Antigen Receptor (CAR) T Cells: Lessons Learned from Targeting of CD19 in B-Cell Malignancies.

Drugs 2017 Mar;77(3):237-245

Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave., Seattle, WA, 98109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40265-017-0690-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5603178PMC
March 2017

Clinical trials of CD19-targeted CAR-modified T cell therapy; a complex and varied landscape.

Expert Rev Hematol 2016 08 4;9(8):719-21. Epub 2016 Jul 4.

a Clinical Research Division , Fred Hutchinson Cancer Research Center , Seattle , WA , USA.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/17474086.2016.1
Publisher Site
http://dx.doi.org/10.1080/17474086.2016.1203251DOI Listing
August 2016

CMRF-56(+) blood dendritic cells loaded with mRNA induce effective antigen-specific cytotoxic T-lymphocyte responses.

Oncoimmunology 2016 Jun 5;5(6):e1168555. Epub 2016 May 5.

ANZAC Research Institute, Concord, NSW, Australia; Sydney Medical School, University of Sydney, Camperdown, NSW, Australia; Department of Haematology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia; Department of Haematology, Concord Repatriation General Hospital, Concord, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/2162402X.2016.1168555DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4938320PMC
June 2016

Acquisition of a CD19-negative myeloid phenotype allows immune escape of MLL-rearranged B-ALL from CD19 CAR-T-cell therapy.

Blood 2016 05 23;127(20):2406-10. Epub 2016 Feb 23.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA; and Department of Medicine, University of Washington, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2015-08-665547DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4874221PMC
May 2016

Chimeric antigen receptor modified T cell therapy for B cell malignancies.

Authors:
Cameron J Turtle

Int J Hematol 2014 Feb 14;99(2):132-40. Epub 2013 Dec 14.

Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue N., Seattle, WA, 98109, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12185-013-1490-xDOI Listing
February 2014

HLA engineering of human pluripotent stem cells.

Mol Ther 2013 Jun 30;21(6):1232-41. Epub 2013 Apr 30.

Department of Medicine, University of Washington, Seattle, Washington 98195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/mt.2013.59DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3677304PMC
June 2013

Engineered T cells for anti-cancer therapy.

Curr Opin Immunol 2012 Oct 18;24(5):633-9. Epub 2012 Jul 18.

Program in Immunology, Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.coi.2012.06.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3622551PMC
October 2012

Augmentation of anti-tumor immunity by adoptive T-cell transfer after allogeneic hematopoietic stem cell transplantation.

Expert Rev Hematol 2012 Aug;5(4):409-25

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/ehm.12.28DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3590108PMC
August 2012

Genetically retargeting CD8+ lymphocyte subsets for cancer immunotherapy.

Curr Opin Immunol 2011 Apr 14;23(2):299-305. Epub 2011 Jan 14.

Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA, 98109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.coi.2010.12.012DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3130496PMC
April 2011

Artificial antigen-presenting cells for use in adoptive immunotherapy.

Cancer J 2010 Jul-Aug;16(4):374-81

Program in Immunology, Clinical Research Division, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PPO.0b013e3181eb33a6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2929753PMC
December 2010

A distinct subset of self-renewing human memory CD8+ T cells survives cytotoxic chemotherapy.

Immunity 2009 Nov 29;31(5):834-44. Epub 2009 Oct 29.

Program in Immunology, Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.immuni.2009.09.015DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2789980PMC
November 2009

Adoptive transfer of virus-specific and tumor-specific T cell immunity.

Curr Opin Immunol 2009 Apr 21;21(2):224-32. Epub 2009 Mar 21.

Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.coi.2009.02.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2720155PMC
April 2009